Breakthrough ventricular fibrillation in a patient with catecholaminergic polymorphic ventricular tachycardia after a decade of stability: A follow-up report
Year: 2025
Type: article
Study design: Case Report
Abstract: Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare but potentially fatal genetic arrhythmia disorder characterized by ventricular tachycardia that is primarily triggered by physical exertion or emotional stress with associated elevations in adrenergic tone. The hallmark arrhythmia is bidirectional or polymorphic ventricular tachycardia (VT), which can deteriorate into ventricular fibrillation (VF), leading to syncope or sudden cardiac death.1 CPVT is most commonly linked to mutations in the RYR2 (autosomal dominant) or CASQ2 (autosomal recessive) genes, both of which impair calcium handling in cardiomyocytes.
Source: HeartRhythm Case Reports
Authors: Alfredo M. Jauregui, Christopher Janson, Scott R. Ceresnak, Jack Winters, Robert H. Pass
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,100
OpenAlex ID: W4416980826
